2019
DOI: 10.1016/j.bmcl.2019.02.034
|View full text |Cite
|
Sign up to set email alerts
|

Recent developments in the synthesis and applications of phosphinic peptide analogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
25
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 23 publications
(25 citation statements)
references
References 81 publications
0
25
0
Order By: Relevance
“…Critical relevance of its activity for cancer progression caused intensive studies to be undertaken to develop new drugs directed towards this enzyme, including enzyme inhibitors and APN-targeted carrier constructs [15,16]. As a consequence, a variety of APN inhibitors have been developed [17][18][19][20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…Critical relevance of its activity for cancer progression caused intensive studies to be undertaken to develop new drugs directed towards this enzyme, including enzyme inhibitors and APN-targeted carrier constructs [15,16]. As a consequence, a variety of APN inhibitors have been developed [17][18][19][20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…Phosphinic dipeptides are generally acknowledged as transition-state analog inhibitors of metallo-aminopeptidases [1][2][3], a large and homogenous class of exopeptidases that specifically cleave the N-terminal amino acid residues of polypeptides and proteins and contain metal ion(s) in their active sites. Being ubiquitously distributed in subcellular organelles, cytoplasm, and cellular membranes throughout all of the biological kingdoms, these enzymes perform critical roles in physiological processes and diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Mammalian, protozoan, and bacterial enzymes of the M01 and M17 families have probably been the most comprehensively studied metallo-aminopeptidases with phosphinic dipeptides [2,5].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The synthesized extended transition state analogs were tested with porcine, human, and plant M1 and M17 aminopeptidases. Mammalian leucine (M1, Ss LAP) and alanyl aminopeptidases (M1, Ss APN and Hs APN) were targeted as inhibition of these enzymes with phosphorus-modified dipeptide analogues was probably the most thoroughly studied [ 17 , 18 ]. LAP and APN are multifunctional broad-band specificity aminopeptidases of known structures, mechanisms of action, and recognized therapeutic potential [ 19 , 20 , 21 ].…”
Section: Resultsmentioning
confidence: 99%